Marker Therapeutics Inc (NASDAQ:MRKR)
| 2.76 BATS BZX Real-Time Price As of 1:07pm ET |  -0.04 / -1.43%Today’s Change | 2.20 Today|||52-Week Range 6.70 | +3.80% Year-to-Date |
Latest MRKR News | Press Releases
No recent news for Marker Therapeutics Inc.
Today’s Trading
| Previous close | 2.80 |
| Today’s open | 2.79 |
| Day’s range | 2.66 - 2.79 |
| Volume | 670 |
| Average volume (3 months) | 32,546 |
| Market cap | $29.3M |
Data as of 1:07pm ET, 01/31/2023
Growth & Valuation
| Earnings growth (last year) | +10.30% |
| Earnings growth (this year) | +34.55% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +166.01% |
| P/E ratio | NM |
| Price/Sales | 58.54 |
| Price/Book | 0.66 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --Winston Pharmaceutic... | 0.00 | 0.00% |
| ---- | ||
| ONTXOnconova Therapeutic... | +0.10 | +9.01% |
| RGLSRegulus Therapeutics... | 0.00 | 0.00% |
Data as of 1:00pm ET, 01/31/2023
Financials
| Next reporting date | March 16, 2023 |
| EPS forecast (this quarter) | -$1.00 |
| Annual revenue (last year) | $1.2M |
| Annual profit (last year) | -$41.9M |
| Net profit margin | -3,372.68% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Houston, Texas |
Forecasts
